|
BSE Code
|
Company
|
Date
|
Purpose
|
|
524502
|
Raaj Medisafe
|
23-Dec-2025
|
Raaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2025 inter alia to consider and approve Next meeting of the Board of Directors of the Company is scheduled to be held on 23.12.2025 inter-alia to consider and to approve:
1. Increase in Authorised Capital
2. Issue of further equity shares by way of Preferential Issue to Select Group of Persons.
3. To convene EGM on 20.01.2026
Other Items as per Agenda attached herewith
|
|
531515
|
Mahan Industries
|
23-Dec-2025
|
Inter-alia, to consider the proposal for shifting of the Registered Office of the Company within the local limits of Ahmedabad city and Any other item with the permission of the Chair and Majority of Directors
|
|
531936
|
Blue Chip India
|
23-Dec-2025
|
Blue Chip India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2025 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors will be held on Tuesday 23rd December 2025 in order to transact the following business:
1. To consider the reduction of share capital of the Company;
2. To Appointed Mr. Manas Ranjan Palo (DIN: 01933994) as an Additional Director (Non-Executive- Independent) of the Company;
3. To Appointed Mrs. Aakansha Vaid (DIN: 02796417) as an Additional Director (Non-Executive- Independent) of the Company;
4. To discuss any other businesses with the permission of the Chair.
This is for your information and record.
|
|
532482
|
Granules India
|
23-Dec-2025
|
Granules India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2025 ,inter alia, to consider and approve proposals for raising funds on a private placement basis by way of preferential issue including the determination of issue price, subject to such regulatory/statutory approvals as may be required.
|
|
533315
|
Innovassynth Inv
|
23-Dec-2025
|
Innovassynth Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2025 inter alia to consider and approve the allotment of securities pursuant to the scheme of merger.
|
|
533632
|
Onelife Capital
|
23-Dec-2025
|
Onelife Capital Advisors Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/12/2025 inter alia to consider and approve To consider discuss and decide various matters in connection with the Rights Issue including the specific terms of the Rights Issue
Onelife Capital Advisors Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2025 ,inter alia, to consider and approve With reference to our earlier intimation dated 12th December 2025, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Right issue Committee Meeting of the Company, originally scheduled on 17th December 2025, has been rescheduled and will now be held on Tuesday, 23rd December 2025, through Video Conferencing/Other Audio-Visual Means (VC/OAVM). The agenda of the meeting remains unchanged
(As per BSE Announcement dated on: 17.12.2025)
|
|
535136
|
NIBE
|
23-Dec-2025
|
NIBE Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2025 inter alia to consider and approve Fund-Raising Proposal
|
|
539251
|
Balkrishna Paper
|
23-Dec-2025
|
Balkrishna Paper Mills Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2025 inter alia to consider and approve Notice of Board Meeting to be held on 23rd December 2025 to consider and approve the Scheme of Reduction of Share Capital and other businesses as per attached letter.
|
|
540181
|
Salem Erode Inv.
|
23-Dec-2025
|
Salem Erode Investments Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/12/2025 inter alia to consider and approve the fund raising by way of issue of Secured Redeemable Non-Convertible Debentures on Private Placement basis
|
|
544549
|
Earkart
|
23-Dec-2025
|
The Board has authorised Mr. Rajhkumar Jain, Independent Director, to undertake a fresh review of the valuation parameters and due diligence of Turtle Maarks LLP and to present a detailed note and discussion before the Board at its next meeting scheduled to be held on Tuesday, 23 December 2025.
|